Safety study of GB18 injection in healthy adults
Part of Cancer, Hormones & metabolism clinical trials.
This early-phase trial tests a new injection called GB18 in healthy adults to see if it is safe and how the body processes it. It may help researchers understand how to treat conditions that involve the immune system.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- You are generally healthy (no serious medical conditions).
- Your body mass index (BMI) is between 18.5 and 26.
- You are not pregnant, nursing, or planning to become pregnant, and will use birth control for 6 months after the study.
- You have not had a live vaccine in the last 28 days, and no recent drug or alcohol misuse.
- You are willing to avoid smoking, certain medications, and blood donation during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational injection called INB301 to see if it can help reduce weight loss and improve appetite in people with cancer-related wasting (cachexia). It is a phase 1/2 study, so it is one of the first times the drug is given to people, and safety is a key goal.
This Phase 1 trial tests a new drug called GB18 to help cancer patients who have experienced significant weight loss and muscle wasting—a condition called cancer cachexia. The drug works by targeting a specific protein involved in weight loss, and researchers want to learn if it can help patients regain weight and strength while also being safe.
This is a first-in-human study of a new injected medication that may help with certain conditions. The trial is looking for healthy volunteers to check the drug's safety and how it works in the body.
This trial tests a new drug, GenSci136, in healthy adults to see if it's safe and how the body processes it. If you qualify, you would receive the drug and be monitored for side effects.
This trial tests a new drug called GB268, which is designed to help your immune system fight cancer. It is for people with advanced solid tumors that have not responded to standard treatments.
This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.
Hear when a new Cancer Cachexia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.